| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Tuberculosis | D014376 | 20 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Nocardia Infections | D009617 | 6 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Hearing Loss, Sensorineural | D006319 | 8 associated lipids |
| Otitis Media | D010033 | 12 associated lipids |
| Carcinoma, Basal Cell | D002280 | 6 associated lipids |
| Arrhythmias, Cardiac | D001145 | 42 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Job V et al. | [Medical-surgical treatment of pulmonary infection with Mycobacterium malmoense]. | 2004 | Rev Mal Respir | pmid:15622347 |
| Dautzenberg B et al. | [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]. | 1994 | Rev Mal Respir | pmid:8041990 |
| Huet D et al. | [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. | 2017 | Rev Mal Respir | pmid:27639948 |
| Schubel K et al. | [Pleuropneumonia due to Mycobacterium chelonae]. | 2011 | Rev Mal Respir | pmid:21482339 |
| Frija-Masson J et al. | [Non-tuberculous mycobacterial infection of a totally implanted perfusion device]. | 2015 | Rev Mal Respir | pmid:25480387 |
| Ramon PM et al. | [Uveitis, arthralgia and pseudo-jaundice in a HIV seronegative patient due to rifabutin]. | 1998 | Rev Mal Respir | pmid:9608993 |
| González C et al. | [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin]. | 2001 | Rev Med Chil | pmid:11510204 |
| Pavié G J et al. | [Assessment of the management of community-acquired pneumonia in adults outpatients]. | 2005 | Rev Med Chil | pmid:16446856 |
| Sánchez H et al. | [Compliance with guidelines for the management of community acquired pneumonia at primary health care centers]. | 2009 | Rev Med Chil | pmid:20361133 |
| Alvarez A et al. | [Antimicrobial susceptibility of Helicobacter pylori strains isolated in Colombia]. | 2009 | Rev Med Chil | pmid:20011937 |
| Fariña N et al. | [Antimicrobial susceptibility of H pylori strains obtained from Paraguayan patients]. | 2007 | Rev Med Chil | pmid:17989858 |
| GarcÃa-Agudo L et al. | [Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test]. | 2009 | Rev Med Chil | pmid:19802419 |
| Vallejos C et al. | [Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients]. | 2007 | Rev Med Chil | pmid:17505573 |
| Poiată A et al. | [Meropenem activity against staphylococci]. | 2005 Jan-Mar | Rev Med Chir Soc Med Nat Iasi | pmid:16607852 |
| Niang M et al. | [Painful nodular lesions]. | 1998 | Rev Med Interne | pmid:9793156 |
| Cinquetti G et al. | [Rare complications of Lemierre's syndrome: septic sternoclavicular joint arthritis and cavitating pneumonia]. | 2009 | Rev Med Interne | pmid:19896753 |
| Leclercq V et al. | [Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine]. | 2005 | Rev Med Interne | pmid:16023268 |
| de Korwin JD | [Helicobacter pylori infection and antimicrobial agents resistance]. | 2004 | Rev Med Interne | pmid:14736561 |
| Scheen AJ | [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. | 1998 | Rev Med Liege | pmid:9555183 |
| Lutgen N et al. | [Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege]. | 2001 | Rev Med Liege | pmid:11256133 |
| Guiot J et al. | [Mycobacterium malmoense infection in an immunocompetent patient]. | 2009 Jul-Aug | Rev Med Liege | pmid:19777918 |
| Flores-Gonzalez JC et al. | [Etiology, clinical presentation and outcome of severe viral acute childhood encephalitis (ECOVE study)]. | 2015 | Rev Neurol | pmid:26108903 |
| Dautzenberg B | [Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. | 1992 | Rev Pneumol Clin | pmid:1296257 |
| Melo-Cristino J et al. | The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. | Rev Port Pneumol | pmid:16572254 | |
| Bronstein JA | [National ranking exam. N63. What could fall at the exam?]. | 2008 | Rev Prat | pmid:18506983 |
| Lamouliatte H et al. | [Treatment of Helicobacter pylori infection]. | 2000 | Rev Prat | pmid:11019637 |
| Roche B et al. | Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. | 1997 | Rev Rhum Engl Ed | pmid:9051864 |
| Colomina RodrÃguez J et al. | [Impact of Integrated Model for Rational Use of Antibiotics in a health area (project MIURA)]. | Rev. Esp. Salud Publica | pmid:20661527 | |
| Ramzy I et al. | GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. | 2016 | Rev. Inst. Med. Trop. Sao Paulo | pmid:27982354 |
| Picoli SU et al. | Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients. | 2014 May-Jun | Rev. Inst. Med. Trop. Sao Paulo | pmid:24878996 |
| Vianna JS et al. | The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. | 2018 | Rev. Inst. Med. Trop. Sao Paulo | pmid:29972462 |
| Estrada-Gómez RA et al. | Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico. | 2007 Mar-Apr | Rev. Invest. Clin. | pmid:17633798 |
| Leal YA et al. | A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy. | 2008 Nov-Dec | Rev. Invest. Clin. | pmid:19378833 |
| Gutiérrez-Castrellón P et al. | Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. | 2012 Mar-Apr | Rev. Invest. Clin. | pmid:22991774 |
| Gélisse P et al. | [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. | 2007 | Rev. Neurol. (Paris) | pmid:18033049 |
| Dalston MO et al. | [Clarithromycin combined with pyrimethamine in cerebral toxoplasmosis--a report of 2 cases]. | 1995 Oct-Dec | Rev. Soc. Bras. Med. Trop. | pmid:8668843 |
| Caliskan R et al. | Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. | Rev. Soc. Bras. Med. Trop. | pmid:26108005 | |
| Paina FA et al. | [Hematological, hemostatic and biochemical alterations induced by clofazimine and clarithromycin, in single and multiple doses, in rats]. | 2008 May-Jun | Rev. Soc. Bras. Med. Trop. | pmid:18719809 |
| Andereya S et al. | Reactive knee and ankle joint arthritis: abnormal manifestation of Legionella pneumophila. | 2004 | Rheumatol. Int. | pmid:14513269 |
| Cohen O et al. | Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori. | 2015 | Rheumatol. Int. | pmid:26210999 |
| Saviola G et al. | Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value--a 24-month single-blind pilot study. | 2013 | Rheumatol. Int. | pmid:23864141 |
| Breda L et al. | Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children. | 2009 | Rheumatol. Int. | pmid:19156420 |
| Saviola G et al. | Clarithromycin in adult-onset Still's disease: a study of 6 cases. | 2010 | Rheumatol. Int. | pmid:20033412 |
| O'Connor MB et al. | Rituximab-induced pulmonary disease. | 2012 | Rheumatol. Int. | pmid:21892654 |
| Haj Yahia S et al. | Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. | 2018 | Rheumatol. Int. | pmid:28975396 |
| Furuya H et al. | SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. | 2017 | Rheumatology (Oxford) | pmid:28371927 |
| Cervin A and Wallwork B | Macrolide therapy of chronic rhinosinusitis. | 2007 | Rhinology | pmid:18085018 |
| Stefansson P et al. | Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. | 1998 | Rhinology | pmid:9923060 |
| Haruna S et al. | A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. | 2009 | Rhinology | pmid:19382498 |
| Murata Y et al. | [Study on the detection methods of Helicobacter pylori from clinical specimens]. | 2002 | Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi | pmid:11895427 |
| Yamane N et al. | [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria]. | 2002 | Rinsho Byori | pmid:12014018 |
| Ozawa S | [Drug-drug interaction in pharmacogenetics and pharmacogenomics]. | 2002 | Rinsho Byori | pmid:11925851 |
| Tomita A et al. | [Analysis of the macrolide resistance gene in penicillin-resistant Streptococcus pneumoniae]. | 2006 | Rinsho Byori | pmid:16989397 |
| Egashira T | [Development and clinical application of invader assay--detection of resistant mutation to clarithromycin in Helicobacter pylori]. | 2006 | Rinsho Byori | pmid:16548239 |
| Kodama M and Fujioka T | [Eradication therapy of Helicobacter pylori infection]. | 2001 | Rinsho Byori | pmid:11307304 |
| Fukuda Y et al. | [The history of Helicobacter pylori]. | 2001 | Rinsho Byori | pmid:11307300 |
| Chen G et al. | [The cause of failure of eradication treatment of Helicobacter pylori]. | 2005 | Rinsho Byori | pmid:16190353 |
| Ohe M and Kohno M | [Three cases of idiopathic thrombocytopenic purpura showing an increase in the platelet count following clarithromycin treatment]. | 2003 | Rinsho Ketsueki | pmid:14639954 |
| Goto H et al. | [Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. | 2001 | Rinsho Ketsueki | pmid:11828723 |
| Sakabe H et al. | [Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori]. | 2004 | Rinsho Ketsueki | pmid:15199751 |
| MORITA R et al. | Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura. | 2009 | Rinsho Ketsueki | pmid:20009444 |
| Yanagimachi M et al. | [Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation]. | 2008 | Rinsho Ketsueki | pmid:18341040 |
| Takahashi T et al. | [Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura]. | 2006 | Rinsho Ketsueki | pmid:16784096 |
| Ohe M and Hashino S | [Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS]. | 2010 | Rinsho Ketsueki | pmid:20467229 |
| Fujikawa K et al. | [A case of Mycobacterium fortuitum meningitis following surgery for meningioma]. | 2006 | Rinsho Shinkeigaku | pmid:17061701 |
| AIDS patients have a new weapon against MAC infection. | 1994 | RN | pmid:8128150 | |
| Sakatani M | [Multi-drug resistant mycobacterial infection]. | 1999 | Ryoikibetsu Shokogun Shirizu | pmid:10088372 |
| Kimang'a AN et al. | Helicobacter pylori: prevalence and antibiotic susceptibility among Kenyans. | 2010 | S. Afr. Med. J. | pmid:20429490 |
| Laving A et al. | Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya. | 2013 | S. Afr. Med. J. | pmid:24300630 |
| Bellelis P et al. | Efficacy of a triple therapy for Helicobacter pylori eradication in a well-developed urban area in Brazil. | 2004 | Sao Paulo Med J | pmid:15257365 |
| Eisig JN et al. | Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients. | 2003 | Sao Paulo Med J | pmid:12751338 |
| Baba K et al. | A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. | 2006 | Sarcoidosis Vasc Diffuse Lung Dis | pmid:16933475 |
| Alsohaibani F et al. | Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection. | Saudi J Gastroenterol | pmid:26228365 | |
| Zullo A et al. | Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis. | Saudi J Gastroenterol | pmid:22249086 | |
| Agah S et al. | Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia. | 2009 Oct-Dec | Saudi J Gastroenterol | pmid:19794266 |
| Kekilli M et al. | Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori. | Saudi J Gastroenterol | pmid:27748322 | |
| Rajendiran S et al. | Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. | 2012 Jul-Aug | Saudi J Gastroenterol | pmid:22824768 |
| Hu JL et al. | Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China. | Saudi J Gastroenterol | pmid:28937021 | |
| Abadi AT et al. | High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. | 2011 Nov-Dec | Saudi J Gastroenterol | pmid:22064338 |
| Dajani AI et al. | Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy? | 2013 May-Jun | Saudi J Gastroenterol | pmid:23680708 |
| Zhang SH et al. | The effect of virulence genotypes of on eradication therapy in children. | Saudi J Gastroenterol | pmid:29652033 | |
| Al Majid FM | Peritonitis due to Mycobacterium fortuitum following gastric banding. | Saudi J Gastroenterol | pmid:20339182 | |
| Shokrzadeh L et al. | Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran. | Saudi J Gastroenterol | pmid:21727733 | |
| Hasan SR et al. | Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori. | Saudi J Gastroenterol | pmid:20065568 | |
| Khan MQ | Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial. | 2008 | Saudi J Gastroenterol | pmid:19568511 |
| Wang J et al. | Two-week triple therapy has a higher Helicobacter pylori eradication rate than 1-week therapy: A single-center randomized study. | Saudi J Gastroenterol | pmid:26655129 | |
| Pellicano R and Fagoonee S | One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015? | Saudi J Gastroenterol | pmid:26655127 | |
| Dajani A et al. | Importance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease. | Saudi J Gastroenterol | pmid:19858579 | |
| Salem EM et al. | Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. | 2010 Jul-Sep | Saudi J Gastroenterol | pmid:20616418 |
| Bezmin Abadi AT et al. | Inefficiency of rapid urease test for confirmation of Helicobacter pylori. | Saudi J Gastroenterol | pmid:21196663 | |
| Rajindrajith S et al. | Helicobacter pylori infection in children. | 2009 | Saudi J Gastroenterol | pmid:19568571 |
| Ranganathan D et al. | Mycobacterium fortuitum peritonitis in a patient receiving continuous ambulatory peritoneal dialysis. | 2013 | Saudi J Kidney Dis Transpl | pmid:24029271 |
| Vafaeimanesh J et al. | Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. | 2014 | Saudi J Kidney Dis Transpl | pmid:24434382 |
| Alfaresi MS et al. | Molecular prevalence of point mutations conferring resistance to clarithromycin in Helicobacter pylori in the United Arab Emirates. | 2005 | Saudi Med J | pmid:15951866 |
| Ghazzawi IM et al. | Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers. | 2004 | Saudi Med J | pmid:15322588 |
| Al-Mobeireek AF | Rapidly growing mycobacterial pulmonary infection in association with severe gastroesophageal reflux disease. | 2002 | Saudi Med J | pmid:12174240 |
| Celen MK et al. | Development of pneumatoceles after viral infection. | 2006 | Saudi Med J | pmid:16830037 |
| Bindayna KM | Antibiotic susceptibilities of Helicobacter pylori. | 2001 | Saudi Med J | pmid:11255612 |
| Paakkanen R et al. | Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies. | 2009 | Scand. Cardiovasc. J. | pmid:19365786 |
| Bjerre M et al. | Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. | 2014 | Scand. J. Clin. Lab. Invest. | pmid:25026506 |